AtriCure hopes to secure FDA clearance for use of its AtriClip device in treating stroke patients. The company plans to start next year a clinical study of the device, which already has been cleared for use in combination with other open-heart surgeries, to evaluate whether it can be used for standalone procedures done to exclude the left atrial appendage, where stroke-causing blood clots often develop.

Full Story:

Related Summaries